ProBioGen Announces Expansion of Commercial Licenses with Emergent BioSolutions for AGE1.CR® Viral Vaccine Manufacturing Production Platform
ProBioGen Signs next GlymaxX® ADCC Technology Deal with TOP 10 Pharma Company for Therapeutic Antibody Platform
ProBioGen Launches Unique Portfolio of Engineered High-Performance Cell Lines for Biopharmaceutical Manufacturing
ProBioGen Introduces Novel Productivity-Boosting Technology for Therapeutic Protein Production: "Pathway Modulator"
ProBioGen and Inhibrx Sign License Deal on GlymaxX® ADCC Technology for Therapeutic Antibodies Development